Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Amin Kamrani, Amir Mehdizadeh, Majid Ahmadi, Leili Aghebati-Maleki & Mehdi Yousefi. (2019) Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells. Expert Opinion on Therapeutic Targets 23:5, pages 447-456.
Read now
Read now
Jian Dai, Li-Juan Xu, Guo-Dong Han, Hai-Tao Jiang, Hai-Lang Sun, Guo-Tai Zhu & Xiao-Ming Tang. (2018) Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 783-790.
Read now
Read now
Xiaojie Chu, Yang Li, Weiwei Huang, Xuejun Feng, Pengyan Sun, Yufeng Yao, Xu Yang, Wenjia Sun, Hongmei Bai, Cunbao Liu & Yanbing Ma. (2018) Combined immunization against TGF-β1 enhances HPV16 E7-specific vaccine-elicited antitumour immunity in mice with grafted TC-1 tumours. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 1199-1209.
Read now
Read now
Moises A. Franco-Molina, Silvia E. Santana-Krímskaya, Erika E. Coronado-Cerda, Carlos Eduardo Hernández-Luna, Diana G. Zarate-Triviño, Pablo Zapata-Benavides, Edgar Mendoza-Gamboa, María C. Rodríguez-Salazar, Reyes Tamez-Guerra & Cristina Rodríguez-Padilla. (2018) Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment. Biotechnology & Biotechnological Equipment 32:4, pages 1028-1035.
Read now
Read now
Alessandro Allegra, Vanessa Innao, Demetrio Gerace, Doriana Vaddinelli, Andrea Gaetano Allegra & Caterina Musolino. (2018) Nanobodies and Cancer: Current Status and New Perspectives. Cancer Investigation 36:4, pages 221-237.
Read now
Read now
Mahdie Jafari, Masoud Moghaddam Pour, Morteza Taghizadeh, Shahin Masoudi & Zahra Bayat. (2017) Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens. Artificial Cells, Nanomedicine, and Biotechnology 45:1, pages 84-89.
Read now
Read now
Articles from other publishers (14)
Ting Li, Silin Huang, Wei Yan, Yu Zhang & Qiang Guo. (2021)
PRUNE2 inhibits progression of colorectal cancer
in vitro
and
in vivo
. Experimental and Therapeutic Medicine 23:2.
Crossref
Crossref
Ajita Jindal, Sounik Sarkar & Aftab Alam. (2021) Nanomaterials-Mediated Immunomodulation for Cancer Therapeutics. Frontiers in Chemistry 9.
Crossref
Crossref
Marlon Osorio, Estefanía Martinez, Tonny Naranjo & Cristina Castro. (2020) Recent Advances in Polymer Nanomaterials for Drug Delivery of Adjuvants in Colorectal Cancer Treatment: A Scientific-Technological Analysis and Review. Molecules 25:10, pages 2270.
Crossref
Crossref
Jessica M. Konen, Jared J. Fradette & Don L. Gibbons. (2019) The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors. Cells 9:1, pages 52.
Crossref
Crossref
Susan T Sharfstein. (2018) Non-protein biologic therapeutics. Current Opinion in Biotechnology 53, pages 65-75.
Crossref
Crossref
Virginia Aragon-Sanabria, Gloria B. Kim & Cheng Dong. 2018. Biomechanics in Oncology. Biomechanics in Oncology
113
138
.
Hannah Frizzell, Jaehyung Park, Natacha Comandante Lou & Kim A. Woodrow. (2017) Role of heterogeneous cell population on modulation of dendritic cell phenotype and activation of CD8 T cells for use in cell-based immunotherapies. Cellular Immunology 311, pages 54-62.
Crossref
Crossref
Sofia Farkona, Eleftherios P. Diamandis & Ivan M. Blasutig. (2016) Cancer immunotherapy: the beginning of the end of cancer?. BMC Medicine 14:1.
Crossref
Crossref
Morteza Motallebnezhad, Leili Aghebati-Maleki, Farhad Jadidi-Niaragh, Hamid Nickho, Hosein Samadi-Kafil, Karim Shamsasenjan & Mehdi Yousefi. (2016) The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies. Tumor Biology 37:9, pages 11711-11721.
Crossref
Crossref
Farhad Jadidi-Niaragh, Fatemeh Atyabi, Ali Rastegari, Esmail Mollarazi, Melika Kiani, Alireza Razavi, Mehdi Yousefi, Nasim Kheshtchin, Hadi Hassannia, Jamshid Hadjati & Fazel Shokri. (2016) Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles. Tumor Biology 37:6, pages 8403-8412.
Crossref
Crossref
HamidReza Mirzaei, Amirhossein Sahebkar, Rasoul Salehi, JavidSadri Nahand, Ehsan Karimi, MahmoudReza Jaafari & Hamed Mirzaei. (2016) Boron neutron capture therapy: Moving toward targeted cancer therapy. Journal of Cancer Research and Therapeutics 12:2, pages 520.
Crossref
Crossref
Melissa A. Gray, Ran N. Tao, Sandra M. DePorter, David A. Spiegel & Brian R. McNaughton. (2016) A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells. ChemBioChem 17:2, pages 155-158.
Crossref
Crossref
Maria Teresa P. de Aquino, Anshu Malhotra, Manoj K. Mishra & Anil Shanker. (2015) Challenges and future perspectives of T cell immunotherapy in cancer. Immunology Letters 166:2, pages 117-133.
Crossref
Crossref
Behdokht Bahrami, Mousa Mohammadnia-Afrouzi, Peyman Bakhshaei, Yaghoub Yazdani, Ghasem Ghalamfarsa, Mehdi Yousefi, Sanam Sadreddini, Farhad Jadidi-Niaragh & Mohammad Hojjat-Farsangi. (2015) Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy. Tumor Biology 36:8, pages 5727-5742.
Crossref
Crossref